Tetrahydrocannabinol (THC) Metabolite, Meconium, Qualitative

Positive cutoff: 5 ng/g
Methodology: Mass spectrometry

This test is designed to detect and document exposure that occurred during approximately the last trimester of a full-term pregnancy, to a common metabolite of pregnancy THC (which may be present in cannabis products). Alternative testing is available to detect other drug exposures. The pattern and frequency of drug(s) used by the mother cannot be determined by this test. A negative result does not exclude the possibility that a mother used drugs during pregnancy. Detection of drugs in meconium depends on extent of maternal drug use, as well as drug stability, unique characteristics of drug deposition in meconium, and the performance of the analytical method. Drugs administered during labor and deliveryn or drugs administered directly to the toinfant after birth may be detected. Detection of drugs in meconium does not insinuate impairment and may not affect outcomes for the infant. Interpretive questions should be directed to the laboratory.

This test does not distinguish between the delta-8 and delta-9 forms of THC or their metabolites.For medical purposes only; not valid for forensic use.